• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov25
Fosun Pharma and RuiZhi Pharma Sign Strategic Cooperation Framework Agreement
14:53
Oct29
ChemPartner released FY2025 9 Months Earnings on October 29 During-Market (BJT), actual revenue CNY 816.85 M, actual EPS CNY 0.0302
01:00
ChemPartner released FY2025 Q3 earnings on October 29 During-Market BJT, actual revenue CNY 283.05 M, actual EPS CNY -0.0363
01:00
Oct22
ChemPartner to Release FY2025 Q3 Earnings on October 30 During-Market BJT
02:02
Aug28
ChemPartner released FY2025 Semi-Annual earnings on August 28 After-Market (BJT), actual revenue CNY 533.8 M, actual EPS CNY 0.051
01:00
ChemPartner released FY2025 Q2 earnings on August 28 After-Market BJT, actual revenue CNY 272.54 M, actual EPS CNY 0.0565
01:00

Schedules & Filings

Schedules
Filings
Oct29
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 283.05 M, Net Income -18.29 M, EPS -0.0363

Aug29
Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug28
Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 272.54 M, Net Income 18.74 M, EPS 0.0565

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More